scispace - formally typeset
Journal ArticleDOI

A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.

Reads0
Chats0
TLDR
The effective range of physicochemical properties presented here can be used in the design of drug-like combinatorial libraries as well as in developing a more efficient corporate medicinal chemistry library.
Abstract
The discovery of various protein/receptor targets from genomic research is expanding rapidly. Along with the automation of organic synthesis and biochemical screening, this is bringing a major change in the whole field of drug discovery research. In the traditional drug discovery process, the industry tests compounds in the thousands. With automated synthesis, the number of compounds to be tested could be in the millions. This two-dimensional expansion will lead to a major demand for resources, unless the chemical libraries are made wisely. The objective of this work is to provide both quantitative and qualitative characterization of known drugs which will help to generate “drug-like” libraries. In this work we analyzed the Comprehensive Medicinal Chemistry (CMC) database and seven different subsets belonging to different classes of drug molecules. These include some central nervous system active drugs and cardiovascular, cancer, inflammation, and infection disease states. A quantitative characterization ...

read more

Citations
More filters
Journal ArticleDOI

SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

TL;DR: The new SwissADME web tool is presented that gives free access to a pool of fast yet robust predictive models for physicochemical properties, pharmacokinetics, drug-likeness and medicinal chemistry friendliness, among which in-house proficient methods such as the BOILED-Egg, iLOGP and Bioavailability Radar are presented.
Journal ArticleDOI

The Blood-Brain Barrier: Bottleneck in Brain Drug Development

TL;DR: This work has shown that the blood-brain barrier provides the platform for CNS drug delivery programs, which should be developed in parallel with traditional CNS drug discovery efforts in the molecular neurosciences.
Journal ArticleDOI

Amide bond formation and peptide coupling

TL;DR: In this article, the authors propose a method to solve the problem of "uniformity" in the literature: 1.0040−4020/$ doi:10.1016/
Journal ArticleDOI

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials.

TL;DR: For 39 agents with both xenograft data and Phase II clinical trials results available, in vivo activity in a particular histology in a tumour model did not closely correlate with activity in the same human cancer histology, casting doubt on the correspondence of the pre-clinical models to clinical results.
Journal ArticleDOI

Drug transport across the blood-brain barrier.

TL;DR: Peptide and antisense radiopharmaceuticals are made brain-penetrating with the combined use of RMT-based delivery systems and avidin–biotin technology to enable new solutions to the problem of BBB drug transport.
References
More filters
Journal ArticleDOI

Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

TL;DR: The main features of the CoMFA approach, exemplified by analyses of the affinities of 21 varied steroids to corticosteroid and testosterone-binding globulins, and a number of advances in the methodology of molecular graphics are described.
Journal ArticleDOI

Semianalytical treatment of solvation for molecular mechanics and dynamics

TL;DR: In this paper, it was shown that the active carbon incorporation catalyst is carbided iron and this conclusion was well supported by bulk carbon to iron stoichiometries of 0.1-0.25 estimated from the TPHT peak areas which were adequate to represent 40-60'36 conversion to bulk carbides such as Fe,C or FeSC2.
Journal ArticleDOI

Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics

TL;DR: Les valeurs d'hydrophobicite de 120 types d'atomes sont evalues pour 893 composes a partir des refractivites molaires de 538 composes and la methode de superposition a ete appliquee a des antibiotiques nucleosides naturels isabelle d'un nombre important de composes.
Journal ArticleDOI

Multiple-Component Condensation Strategies for Combinatorial Library Synthesis

TL;DR: This Account focuses on multiple-component condensations (MCCs) as one subset of strategies for the generation of compound libraries, and it is instructive to contrast this approach with linear synthesis to highlight the differences in methods, potential library size, and output format.
Journal ArticleDOI

Structure-based strategies for drug design and discovery.

TL;DR: The combination of molecular structure determination and computation is emerging as an important tool for drug development and will be applied to acquired immunodeficiency syndrome (AIDS) and bacterial drug resistance.
Related Papers (5)